{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:29:43Z","timestamp":1787509783159,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.nbd.2008.09.026","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T12:06:56Z","timestamp":1226405216000},"page":"141-147","source":"Crossref","is-referenced-by-count":32,"title":["Network biomarkers for the diagnosis and treatment of movement disorders"],"prefix":"10.1016","volume":"35","author":[{"given":"Kathleen L.","family":"Poston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eidelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.09.026_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1212\/01.wnl.0000183359.50822.f2","article-title":"Progression of motor impairment and disability in Parkinson disease: a population-based study","volume":"65","author":"Alves","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib2","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/brain\/awl162","article-title":"Network modulation in the treatment of Parkinson's disease","volume":"129","author":"Asanuma","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib3","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.21453","article-title":"Defining mild cognitive impairment in Parkinson's disease","volume":"22","author":"Caviness","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1602\/neurorx.2.2.361","article-title":"Neuroimaging and therapeutics in movement disorders","volume":"2","author":"Eckert","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2008.09.026_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cnr.2007.05.001","article-title":"The application of network mapping in differential diagnosis of parkinsonian disorders","volume":"6","author":"Eckert","year":"2007","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.09.026_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","article-title":"FDG PET in the differential diagnosis of parkinsonian disorders","volume":"26","author":"Eckert","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2008.09.026_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.21185","article-title":"Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging","volume":"22","author":"Eckert","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S1474-4422(07)70245-4","article-title":"Assessment of the progression of Parkinson's disease: a metabolic network approach","volume":"6","author":"Eckert","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mds.21933","article-title":"Abnormal metabolic networks in atypical parkinsonism","volume":"23","author":"Eckert","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib10","first-page":"127","article-title":"Abnormal brain networks in DYT1 dystonia","volume":"78","author":"Eidelberg","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00019052-199808000-00007","article-title":"Functional brain networks in movement disorders","volume":"11","author":"Eidelberg","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","article-title":"The metabolic topography of parkinsonism","volume":"14","author":"Eidelberg","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2008.09.026_bib13","first-page":"378","article-title":"Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET","volume":"36","author":"Eidelberg","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2008.09.026_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.48.4.927","article-title":"The metabolic anatomy of Tourette's syndrome","volume":"48","author":"Eidelberg","year":"1997","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.nbd.2008.09.026_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/brain\/120.8.1315","article-title":"Metabolic correlates of pallidal neuronal activity in Parkinson's disease","volume":"120","author":"Eidelberg","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.410440304","article-title":"Functional brain networks in DYT1 dystonia","volume":"44","author":"Eidelberg","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.50.5_Suppl_5.S1","article-title":"Classification of dystonia","volume":"78","author":"Fahn","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib18","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the Progression of Parkinson's Disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2008.09.026_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/mds.21423","article-title":"Gene transfer therapy for neurodegenerative disorders","volume":"22","author":"Feigin","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib20","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1212\/WNL.57.11.2083","article-title":"Metabolic correlates of levodopa response in Parkinson's disease","volume":"57","author":"Feigin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib21","first-page":"1591","article-title":"Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study","volume":"42","author":"Feigin","year":"2001","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2008.09.026_bib22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/mds.10270","article-title":"Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism","volume":"17","author":"Feigin","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib23","doi-asserted-by":"crossref","first-page":"19559","DOI":"10.1073\/pnas.0706006104","article-title":"Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease","volume":"104","author":"Feigin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.09.026_bib24","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington's disease","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.20678","article-title":"Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG)","volume":"21","author":"Geser","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.neuroimage.2008.01.056","article-title":"Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease","volume":"40","author":"Habeck","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2008.09.026_bib27","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.0582-08.2008","article-title":"Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease","volume":"28","author":"Hirano","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.026_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","article-title":"Metabolic brain networks associated with cognitive function in Parkinson's disease","volume":"34","author":"Huang","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2008.09.026_bib29","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","article-title":"Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2008.09.026_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1212\/WNL.55.5.673","article-title":"The metabolic topography of essential blepharospasm: a focal dystonia with general implications","volume":"55","author":"Hutchinson","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib34","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","article-title":"Functional decline in Parkinson\u2019s disease","volume":"58","author":"Jankovic","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib35","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2008.09.026_bib36","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1002\/mds.10163","article-title":"Postoperative management of subthalamic nucleus stimulation for Parkinson's disease","volume":"17","author":"Krack","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib37","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/brain\/awn031","article-title":"Metabolic correlates of subthalamic nucleus activity in Parkinson's disease","volume":"131","author":"Lin","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s007020050050","article-title":"Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy","volume":"105","author":"Litvan","year":"1998","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.nbd.2008.09.026_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2008.09.026_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/hbm.20033","article-title":"Executive processes in Parkinson's disease: FDG-PET and network analysis","volume":"22","author":"Lozza","year":"2004","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2008.09.026_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","article-title":"Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility","volume":"27","author":"Ma","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2008.09.026_bib42","first-page":"A274","article-title":"Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study","volume":"64","author":"Marek","year":"2005","journal-title":"Neurology"},{"issue":"Pt 12","key":"10.1016\/j.nbd.2008.09.026_bib43","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/brain\/120.12.2197","article-title":"Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing","volume":"120","author":"Moeller","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib44","first-page":"1264","article-title":"Reproducibility of regional metabolic covariance patterns: comparison of four populations","volume":"40","author":"Moeller","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2008.09.026_bib45","first-page":"A174","article-title":"Assessing the microlesion effect of STN DBS electrode implantation with FDG PET","volume":"70","author":"Pourfar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-008-0720-2","article-title":"Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)","volume":"255","author":"Riedel","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib47","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2008.09.026_bib48","first-page":"M1","article-title":"Highly automated computer-aided diagnosis of neurological disorders using functional imaging","volume":"6144","author":"Spetsieris","year":"2006","journal-title":"Proc. of S.P.I.E."},{"key":"10.1016\/j.nbd.2008.09.026_bib49","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/brain\/awl346","article-title":"Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease","volume":"130","author":"Stefani","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.026_bib50","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.1232","article-title":"Metabolic changes following subthalamotomy for advanced Parkinson's disease","volume":"50","author":"Su","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0361-9230(02)00857-2","article-title":"Posterior parietal cortex projections to the ventral lateral and some association thalamic nuclei in Macaca mulatta","volume":"59","author":"Taktakishvili","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2008.09.026_bib52","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson\u2019s disease progression","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2008.09.026_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ana.10418","article-title":"Primary dystonia: is abnormal functional brain architecture linked to genotype?","volume":"52","author":"Tro\u0161t","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib54","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3171\/jns.2003.99.5.0872","article-title":"Evolving metabolic changes during the first postoperative year after subthalamotomy","volume":"99","author":"Tro\u0161t","year":"2003","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.nbd.2008.09.026_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroimage.2005.12.024","article-title":"Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease","volume":"31","author":"Tro\u0161t","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2008.09.026_bib56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.58.3.396","article-title":"Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up","volume":"58","author":"Vingerhoets","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.58.1.120","article-title":"TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia","volume":"58","author":"Walker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2008.09.026_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.09.026_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.20.11_Part_2.79","article-title":"Pathology of the torsion dystonias (dystonia musculorum deformans)","volume":"20","author":"Zeman","year":"1970","journal-title":"Neurology"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108002489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108002489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T08:30:28Z","timestamp":1545640228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0969996108002489"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.09.026","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}